1 |
Ferrara, N., VEGF and the quest for tumor angiogenesis factors. Nat. Rev. Cancer, 2, 795-803 (2002)
DOI
PUBMED
ScienceOn
|
2 |
Khatri, J.J., Johnson, C., Magid, R., Lessner, S. M., Laude, K. M., Dikalov, S. I., Harrison D.G., Sung H. J., Rong, Y., and Galis Z. S., Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation, 109, 520-525 (2004)
DOI
ScienceOn
|
3 |
Lee, S. J., Lee, H. M., Ji, S. T., Lee, S. R., Mar, W., and Gho, Y. S., 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor. Cancer Lett., 208, 89-94 (2004)
DOI
ScienceOn
|
4 |
Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846 (1993)
DOI
ScienceOn
|
5 |
Shalaby, F., Rossant, J., Yamaguch, T. P., Gertsenstein, M., Wu, X.F., Breitman, M. L., and Schuh, S. C., Failure of bloodisland formation vasculogenesis in Flk-1-deficient mice. Nature, 376 62-66 (1995)
DOI
ScienceOn
|
6 |
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W., Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442 (1996)
DOI
ScienceOn
|
7 |
Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Frrarara, N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309 (1989)
DOI
PUBMED
|
8 |
Risau, W., Angiogenic growth factors. Prog. Growth Factor Res., 2, 71-79 (1990)
DOI
PUBMED
ScienceOn
|
9 |
Kim, C. W., Lee, H. M., Lee, T. H., Kang, C., Kleinman, H. K., and Gho, Y. S., Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res., 62, 6312-6317 (2002a)
|
10 |
Gospodarowicz, D., Abraham, J. A., and Schilling, J., Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. U.S.A., 86, 7311-7315 (1989)
DOI
|
11 |
Kondo, T., Ohta, T., Igura, K., Hara, Y., and Kaji, K., Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett., 180, 139-144 (2002)
DOI
ScienceOn
|
12 |
Bae, D. G., Gho, Y. S., Yoon, W. H., and Chae, C. B., Argininerich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J. Biol. Chem., 275, 13588-13596 (2000)
DOI
ScienceOn
|
13 |
Folkman, J., What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst., 82, 4-6 (1991)
|
14 |
Kim, Y. M., Hwang, S., Kim, Y. M., Pyun, B. J., Kim, T. Y., Lee, S. T., Gho, Y. S., and Kwon, Y. G., Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem., 277, 27872-27879 (2002b)
DOI
ScienceOn
|
15 |
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439 (1996)
DOI
ScienceOn
|
16 |
Veikkola, T. and Alitalo, K., VEGFs, receptors and angiogenesis. Semin. Cancer Biol., 9, 211-220 (1999)
DOI
PUBMED
ScienceOn
|
17 |
Boehm-Viswanathan, T., Is angiogenesis inhibition the Holy Grail of cancer therapy? Curr. Opin. Oncol., 12, 89-94 (2000)
DOI
PUBMED
ScienceOn
|
18 |
Lamy, S., Gingras, D., and Beliveau, R., Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res., 62, 381-385 (2002)
|
19 |
Ncosia, R. F., Tchao, R., and Leighton, J., Angiogenesisdependent tumor spread in reinforced fibrin clot culture. Cancer Res., 43, 2159-2166 (1983)
|
20 |
Nonaka, G. I., Tanaka, T., Nita, M., and Nishioka, I., A dimeric hydrolysable tannin, sanguiin H-6 from Sanguisorba officinalis L. Chem. Pharm. Bull., 30, 2255-2257 (1982)
DOI
|